sharing; smarter health systems; epidemiology; barriers; health data; law and ethics
Martani Andrea, Hummel Patrik (2022), Eine neue Generation des Datenschutzes? Gegenwärtige Unvollständigkeit, mögliche Lösungswege und nächste Schritte, Springer Berlin Heidelberg, Berlin, Heidelberg, 27-54.
Geneviève Lester Darryl, Martani Andrea, Elger Bernice Simone, Wangmo Tenzin (2021), Individual notions of fair data sharing from the perspectives of Swiss stakeholders, in
BMC Health Services Research, 21(1), 1007-1007.
Martani Andrea, Erard Frédéric, Casonato Carlo, Elger Bernice Simone (2021), The devil is in the details: an analysis of patient rights in Swiss cancer registries, in
Journal of Medical Ethics, medethics--medethics-.
Martani Andrea (2021), Comment on: Research projects in human genetics in Switzerland: analysis of research protocols submitted to cantonal ethics committees in 2018, in
Swiss Medical Weekly, w20521.
Martani Andrea, Geneviève Lester Darryl, Egli Sophia Mira, Erard Frédéric, Wangmo Tenzin, Elger Bernice Simone (2021), Evolution or Revolution? Recommendations to Improve the Swiss Health Data Framework, in
Frontiers in Public Health, 9, 638.
Geneviève Lester Darryl, Martani Andrea, Perneger Thomas, Wangmo Tenzin, Elger Bernice Simone (2021), Systemic Fairness for Sharing Health Data: Perspectives From Swiss Stakeholders, in
Frontiers in Public Health, 9, 418.
Martani Andrea, Geneviève Lester Darryl, Elger Bernice, Wangmo Tenzin (2021), 'It’s not something you can take in your hands'. Swiss experts’ perspectives on health data ownership: an interview-based study, in
BMJ Open, 11(4), e045717-e045717.
Geneviève Lester Darryl, Martani Andrea, Shaw David, Elger Bernice Simone, Wangmo Tenzin (2020), Structural racism in precision medicine: leaving no one behind, in
BMC Medical Ethics, 21(1), 17-17.
Martani Andrea, Geneviève Lester Darryl, Poppe Christopher, Casonato Carlo, Wangmo Tenzin (2020), Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects, in
BMC Medical Ethics, 21(1), 3-3.
Martani Andrea, Egli Philipp, Widmer Michael, Elger Bernice (2020), Data protection and biomedical research in Switzerland: setting the record straight, in
Swiss Medical Weekly, 150, w20332.
Martani Andrea, Geneviève Lester Darryl, Pauli-Magnus Christiane, McLennan Stuart, Elger Bernice Simone (2019), Regulating the Secondary Use of Data for Research: Arguments Against Genetic Exceptionalism, in
Frontiers in Genetics, 10, 1254.
Geneviève Lester Darryl, Martani Andrea, Mallet Maria Christina, Wangmo Tenzin, Elger Bernice Simone (2019), Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review, in
PLOS ONE, 14(12), e0226015-e0226015.
Martani Andrea, Shaw David, Elger Bernice Simone (2019), Stay fit or get bit - ethical issues in sharing health data with insurers’ apps, in
Swiss Medical Weekly, (w20089), 149.
Geneviève Lester Darryl, Martani Andrea, Wangmo Tenzin, Paolotti Daniela, Koppeschaar Carl, Kjelsø Charlotte, Guerrisi Caroline, Hirsch Marco, Woolley-Meza Olivia, Lukowicz Paul, Flahault Antoine, Elger Bernice Simone (2019), Participatory Disease Surveillance Systems: Ethical Framework, in
Journal of Medical Internet Research, 21(5), e12273-e12273.
McLennan Stuart, Maritz Roxanne, Shaw David, Elger Bernice (2018), The inconsistent ethical oversight of healthcare quality data in Switzerland., in
Swiss medical weekly, 148, 14637-14637.
Geneviève Lester Darryl, Wangmo Tenzin, Dietrich Damien, Woolley-Meza Olivia, Flahault Antoine, Elger Bernice Simone (2018), Research Ethics in the European Influenzanet Consortium: Scoping Review, in
JMIR Public Health and Surveillance, 4(4), e67-e67.
McLennan Stuart, Shaw David, Celi Leo Anthony (2018), The challenge of local consent requirements for global critical care databases, in
Intensive Care Medicine, 1-3.
Valid and comparable data, including outcome, diagnosis, treatment, risk factors etc., are an important means to reduce over- and underuse of resources in a smarter health care system. Acquisition, analysis, and sharing of such data is a priority on the agenda of 2016 and beyond. In the US, a number of initiatives are taking place to coordinate and harmonize high quality collection and analysis of health data to enable precision medicine and to rationalize treatment of chronic diseases. The aim is to obtain comprehensive comparative data for evidence-based public health and health care. In order to advance smarter medicine, in the US a number of data collection initiatives exist where data from ambulatory or inpatient hospital care is collected routinely and helps to identify better measures and to answer critical questions in the clinical research agenda. Examples are the outpatient clinical registry called “Guideline Advantage (TGA)”, or the National Hospital Care Survey NHCS and National Hospital Ambulatory Medical Care Survey, NHAMCS. To improve evidence-based, smart health care, data from various hospitals, ambulatory care providers, researchers and insurance companies should be combined. Thus, the concept that collection and analysis of health data can remain the task of “a single investigator in a single laboratory for a single purpose” needs to be abandoned. Integrating such local and national data into a coherent network of resources and infrastructure that allows for the efficient and ethical sharing of data, as recommended by the NIH, is urgently needed in Switzerland. At present, data collecting entities tend to prefer using their own clinical or other indicators for success and outcome which is a clear weakness for the Swiss health care system. Efforts are urgently needed to improve (i.) standardization and comparability of data and indicators, (ii.) availability of data from different sources including insurance companies, (iii.) increased veracity and (iv.) completeness of data, comprising the routine collection of valid health and quality indicators. Within and across countries, collaborative acquisition and analysis of comparable health data (and biological samples) is hampered by a number of barriers. In comparison to other European countries and the US, Switzerland is lagging behind. While some barriers, such as the cantonal structure, are evident, others are yet unknown and need urgently to be assessed in more detail, in order to enable smarter health care in Switzerland. The present project will build on previous experience of the two main applicants. BE has worked on barriers to sharing concerning genetic databanks and TP is an expert in health care quality control and evaluation. The aim of this project is to provide urgently needed knowledge on how to overcome barriers to implement high quality, comparable health data collection in Switzerland. The study is at the same time an intervention towards the facilitation of smart data collection as it will not only obtain knowledge, but make key stakeholders and decision makers aware of the need for harmonized good quality data and involve them actively in the search for solutions to overcome barriers.Objectives, methods and study parts are the following:i.Identify success mechanisms, barriers and needs in Switzerland: using a literature search and theoretical analysis, we will describe factors that facilitated past success stories of harmonized health data collection in Switzerland (e.g. HIV-cohort, SAPALDIA, CHUV-biobank), analyse what is known about barriers, and identify needs in Switzerland, e.g. types of needed data, including harmonised tools and indicators used abroad and susceptible to be useful in Switzerland. This includes an assessment of legal and ethical barriers.ii.Explore success factors in other countries: semi-structured interviews will be conducted with approximately 15-25 decision makers and experts in institutions that developed efficient data collection tools in other countries, including those with health care systems comparable to Switzerland. iii.Understand decision makers and key stakeholders’ attitudes and knowledge to identify barriers and propose concrete solutions via a Delphi process: semi-structured interviews will be carried out with 20-30 hospital directors, hospital data managers, insurance company representatives and other stakeholders involved in or influencing collection of relevant data in Switzerland and 20-30 health data researchers and Swiss data experts. The Delphi approach will be concluded using a questionnaire and workshops that extend into part iv.iv.Inform and disseminate findings: this objective is already integrated in part iii. as experts and stakeholders will not only be asked about their experience and attitudes, but also informed about needs and facilitators identified in parts i. and ii. Study results will also be disseminated through the usual scientific vectors (conferences, publications etc.).v.Based on expert consensus, produce concrete, detailed and practically useful recommendations to inform policy makers how to reduce barriers and further good quality health data collection in Switzerland.